News und Analysen
Amgen Stock: New All-Time Highs Ahead After Earnings Beat
Amgen Inc. (NASDAQ: AMGN) just delivered a strong beat-and-raise quarter. That’s pushed the stock to within striking distance of its 52-week high. That also puts it within striking distance of a
Netflix Stock Split Explained: What It Means for Investors
In a headline-grabbing move, Netflix (NASDAQ: NFLX) just announced its first stock split in a decade. Investors want to know—is this development simply cosmetic, or could it drive real value for
Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings
If you’re a parent, you’ve likely battled with your children over different options at dinner time. What kid wouldn’t love to eat hot dogs for dinner every night and then wash it down with a
Why Investors Shouldn’t Fear the Dip in Microsoft Stock
Microsoft Corp. (NASDAQ: MSFT) is down 2% since its earnings report in late October not due to weak results, but because investors are closely watching its capital expenditures. As the company
CAVA Stock Looking for Direction After Earnings Miss
CAVA Group Inc. (NYSE: CAVA) stock is down a fraction in midday trading the day after the company delivered a disappointing, but not surprising, third-quarter earnings report.
For the quarter
After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Meta Platforms (NASDAQ: META) just saw its biggest post-earnings fall in three years.
Shares dropped by over 11% on Oct. 30 as investors reacted to the company’s Q3 2025 earnings and commentary
Cisco's Turning Point? The Market's Most Overlooked AI Play
A major Wall Street firm has made a bold call on a well-known tech giant, suggesting its growth story may be fundamentally misunderstood by the market. On Nov. 3, UBS upgraded Cisco Systems
Follow the Money: 3 Stocks With High Institutional Ownership
When it comes to investing, strong opinions are common, but identifying long-term opportunities often comes down to following the smart money, i.e., institutional investors. Keeping an eye on
Dutch Bros Beats Earnings for 11th Consecutive Quarter
Shares of coffee retail chain Dutch Bros (NYSE: BROS) climbed 4% in after-hours trading on Wednesday following the company’s blowout Q3 earnings call.
Dutch Bros announced that it beat on
AMD’s Price Pullback Equals Opportunity: The Big Gains Are Coming
Advanced Micro Devices' (NASDAQ: AMD) November price pullback is an opportunity for investors to load up on this stock. While indicating a peak, this is a near-term quality peak driven by market
Alphabet Aktie: KI-Wette zündet!
Google-Mutter Alphabet beweist eindrucksvoll: Wer massiv in künstliche Intelligenz investiert, wird vom Markt belohnt.…
Der Beitrag Alphabet Aktie: KI-Wette zündet! erschien zuerst auf kapitalmarkte
Mastercard Aktie: Blockchain-Revolution startet!
Während traditionelle Banken noch über Blockchain-Technologie diskutieren, geht Mastercard bereits in die Offensive. Der…
Der Beitrag Mastercard Aktie: Blockchain-Revolution startet! erschien zuerst
Why Vertical Aerospace Stock Could Double After This Flight Test
On Nov. 4, Vertical Aerospace (NYSE: EVTL) delivered a third-quarter 2025 business update that created a fascinating paradox for investors. The company announced that it was on the cusp of its
AI Stocks Are Surging—But Volatility Could Be the Next Big Test
It’s hard to open your phone or turn on the news without hearing about AI. It’s the buzzword of the decade, and maybe of our lifetime. From chatbots and driverless cars to data centers and chip
DuPont's Spinoff Unlocks 2 Paths to Profit
DuPont de Nemours (NYSE: DD) has officially reshaped its future, completing the spinoff of its high-tech electronics division into a new, publicly traded entity: Qnity Electronics (NYSE: Q).
McKesson Aktie: Quartalszahlen-Showdown!
Heute Abend steht für McKesson der große Stresstest an: Der Healthcare-Konzern legt nach Börsenschluss…
Der Beitrag McKesson Aktie: Quartalszahlen-Showdown! erschien zuerst auf kapitalmarktexperten.
Why Apple's Next Quarter Could Be a "Prove It" iPhone 17 Moment
Over recent years, tech giant Apple (NASDAQ: AAPL) has lost its distinction as the most-watched stock in the market. The company’s sluggish product sales growth has led to it becoming a less
Gartner Aktie: Paradox der Zahlen
Ein überraschender Gewinnsprung und eine kräftige Prognoseanhebung – doch die Aktie stürzt auf ein…
Der Beitrag Gartner Aktie: Paradox der Zahlen erschien zuerst auf kapitalmarktexperten.de.
Quelle
Is Alphabet a Buy After Its Blowout Earnings?
Alphabet (NASDAQ: GOOGL) just reasserted its dominance in tech and AI after delivering one of its strongest quarters in company history. The third-quarter earnings smashed expectations across
Intel's SambaNova Play Isn't an Acquisition, It's an Ambush
Recent reports that Intel Corporation (NASDAQ: INTC) is in early discussions to acquire artificial intelligence (AI) chip designer SambaNova Systems have ignited speculation across the market.
Alphabet Aktie: Billionen-Rekord!
Google-Mutter Alphabet hat den Kapitalmarkt mit den jüngsten Quartalszahlen regelrecht überrollt. Erstmals in der…
Der Beitrag Alphabet Aktie: Billionen-Rekord! erschien zuerst auf kapitalmarktexper
Amazon vs. Apple: Which Mag 7 Is the Better Buy?
It’s been a lackluster year for Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL). While both outperformed the S&P 500 over the past 12 months, their returns fell short of investor expectations in a
Is Starbucks Quietly Setting Up for a Major 2026 Comeback?
Starbucks (NASDAQ: SBUX) is not out of the weeds—far from it—but the most recent earnings results reveal operational improvements that suggest it is still a good buy for 2026.
Among the
MetLife Aktie: Entscheidungstag!
Heute steht die MetLife-Aktie am Scheideweg: Ex-Dividende-Termin und Q3-Zahlen morgen prägen die Stimmung. Während…
Der Beitrag MetLife Aktie: Entscheidungstag! erschien zuerst auf kapitalmarktexper
Starke Verkaufszahlen für Cresemba® (Isavuconazol) in Europa lösen USD 30 Mio. Meilensteinzahlung an Basilea aus
Ad hoc-Mitteilung gemäss Art. 53 KR
Allschwil, 4. November 2025
Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem



